2007
DOI: 10.1016/j.contraception.2007.05.091
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
65
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 121 publications
(71 citation statements)
references
References 16 publications
3
65
0
3
Order By: Relevance
“…ACCEPTED MANUSCRIPT 11 The suggestion of using LNG-IUS was based on its ability to down-regulate estrogen receptors (ER) in endometrial tissues and its decidualization with subsequent atrophy of the endometrium [12]. In addition, the LNG-IUS has a pain-relieving effect through the reduction of prostaglandin production within the endometrium and induction of adenomyosis foci atrophy [13].…”
Section: Accepted Manuscriptmentioning
confidence: 99%
See 1 more Smart Citation
“…ACCEPTED MANUSCRIPT 11 The suggestion of using LNG-IUS was based on its ability to down-regulate estrogen receptors (ER) in endometrial tissues and its decidualization with subsequent atrophy of the endometrium [12]. In addition, the LNG-IUS has a pain-relieving effect through the reduction of prostaglandin production within the endometrium and induction of adenomyosis foci atrophy [13].…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…The LNG-IUS group received LNG-IUS (Mirena; Bayer Schering Healthcare AG, Bayer HealthCare, Berlin, Germany), inserted according to the manufacturer's instructions [12]. TVS ascertained proper insertion of the device immediately after insertion.…”
Section: Interventionmentioning
confidence: 99%
“…Over 70 % of women were satisfi ed with their treatment. Another study enrolled 29 women to receive the LNG-IUD who reported heavy, painful menses and had MRI fi ndings of adenomyosis and followed subjects over time for changes in bleeding pattern and menstrual pain scores [ 6 ]. Heavy menses resolved in all 29 women, with 2 reporting regular menses with normal fl ow, 10 reporting unpredictable spotting, 9 reporting oligomenorrhea, and 8 reporting amenorrhea 6 months after insertion.…”
Section: Abnormal Uterine Bleeding-adenomyosis (Aub-a)mentioning
confidence: 98%
“…The effects of medical treatments, such as progestin, oral contraceptives or GnRH agonists are transient [3]. Recent studies have demonstrated that levonorgestrel-releasing intrauterine devices are effective for the management of adenomyosis in women with dysmenorrhea and menorrhagia [16,17]. However, the adverse effects of prolonged exposure to progestin treatment, such as headache, breast tenderness, seborrhea, acne and weight gain, may diminish long-term patient satisfaction [18].…”
Section: Discussionmentioning
confidence: 99%